Body Good Studio
INSURANCE GUIDES

What Is the BALANCE Model? GLP-1 Coverage Future (2026)

Dr. Linda Moleon, MDJune 29, 2026

the short answer

The BALANCE Model is a federal program that aims to expand GLP-1 access by negotiating lower prices for state Medicaid programs and, eventually, Medicare Part D. State Medicaid agencies can opt in starting May 2026. The Medicare Part D portion has been delayed indefinitely, so the temporary GLP-1 Bridge was extended through the end of 2027 to fill the gap.

what BALANCE is trying to do

It pairs two things: negotiated, lower GLP-1 prices and required lifestyle support. The goal is to make these medications affordable for Medicaid and Medicare populations while controlling cost to taxpayers, and to learn whether combining medication with lifestyle help produces better long-term results.

the timeline that matters

  • • State Medicaid programs can opt in starting May 2026, with applications open through mid-2026.

  • • The Medicare Part D portion, originally planned for 2027, has been delayed indefinitely.

  • • The Medicare GLP-1 Bridge was extended through December 31, 2027 to bridge that gap.
  • which drugs qualify

    Eligible products act on GLP-1 or related receptor pathways and have shown a meaningful average reduction in body weight in clinical trials. The practical list depends on which manufacturers choose to participate, since the program is voluntary on all sides.

    lifestyle support is part of the deal

    Under BALANCE, people receiving a GLP-1 for weight management are also offered a lifestyle support program at no cost. The medication is treated as one part of care, not the whole of it.

    balance is about access plus support, not medication alone.

    what it means for you, and the 2028 question

    If your state opts in, Medicaid access may broaden. For Medicare, the Bridge carries weight-loss coverage through 2027, but the path after that is uncertain while the Part D portion is on hold. If you start treatment now, it is worth planning for continuity rather than assuming coverage will simply roll forward.

    questions people ask

    What is the BALANCE Model?

    A federal program that negotiates GLP-1 prices so state Medicaid programs and, eventually, Medicare Part D plans can cover them more affordably, paired with lifestyle support.

    When does it start?

    State Medicaid agencies can opt in starting May 2026. The Medicare Part D portion has been delayed indefinitely, and the temporary GLP-1 Bridge was extended through the end of 2027 to fill the gap.

    Does BALANCE guarantee I will be covered?

    No. Participation is voluntary for states, plans, and manufacturers, and eligibility rules still apply. It expands access where the pieces line up, not everywhere.

    Which drugs qualify?

    Products that act on GLP-1 or related pathways and have been shown to reduce body weight by a meaningful amount in clinical trials. The exact list depends on manufacturer participation.

    See if you qualify and get started

    _This article is for education and is not medical advice. Coverage rules change often and vary by plan, state, and diagnosis; confirm current details with your plan or at cms.gov before acting. Reviewed by Dr. Linda Moleon, MD. If a GLP-1 might be right for you, talk with a licensed clinician._

    Ready to get started?

    Take our quiz to find the perfect program for you.

    Take the Quiz